The presence of bivalent H3K4me3 and H3K27me3 modifications at MHC-I APP gene promoters was observed in a range of human MHC-I-deficient cancers as well as mouse and Tasmanian devil tumors (Figures 7C and S7E). Here, APP is linked to cancer.